Position in LENZ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,681,367
-$2,445,705 QoQ
Shares Held
183,756
-28.8% QoQ
Ownership
0.586%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 99.9346960099262.ToString("F0")%
Shared 0.ToString("F0")%
None 0.0653039900737935.ToString("F0")%
Common Shares in LENZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. LENZ ranks #231 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in LENZ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,681,367 | 183,756 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,127,072 | 257,942 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,922,635 | 41,276 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $589,607 | 22,933 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,437,321 | 49,786 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $784,701 | 33,054 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $228,625 | 13,223 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||